Trial meets both primary and key secondary endpoints LAVAL, QB – Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health” or the “Company”) announced positive topline results from the Company’s Phase… Read More
OTTAWA, ON – The impact of climate change is widespread – it affects our environment, our communities, and our health. It also means an increase in climate-sensitive infectious diseases. The… Read More
OTTAWA, ON – Supporting research and innovation and connecting Canada’s researchers and entrepreneurs are essential in order to continue tackling some of the world’s most pressing challenges, such as climate… Read More
The Honourable Mark Holland, Minister of Health, announced four new appointments as members to the Canadian Institutes of Health Research (CIHR) Governing Council. Mélanie Caron is the Associate Director, Drug… Read More
KIRKLAND, QC & MISSISSAUGA, ON – Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Eisai announce that KEYTRUDA®, Merck’s anti-PD-1 therapy, plus LENVIMA®, an orally… Read More
